Mutual Advisors LLC Acquires 346 Shares of The Cigna Group (NYSE:CI)

Mutual Advisors LLC boosted its holdings in The Cigna Group (NYSE:CIFree Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,075 shares of the health services provider’s stock after purchasing an additional 346 shares during the period. Mutual Advisors LLC’s holdings in The Cigna Group were worth $1,426,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Ulland Investment Advisors LLC grew its position in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new position in The Cigna Group in the third quarter valued at $37,000. ORG Wealth Partners LLC bought a new position in The Cigna Group in the fourth quarter valued at $34,000. Harbor Capital Advisors Inc. bought a new position in The Cigna Group in the third quarter valued at $45,000. Finally, Intact Investment Management Inc. bought a new position in shares of The Cigna Group in the 3rd quarter valued at about $69,000. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on CI shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a report on Monday, November 4th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Barclays lifted their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Stephens reaffirmed an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a report on Friday, November 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $395.93.

Check Out Our Latest Research Report on CI

The Cigna Group Price Performance

Shares of NYSE:CI opened at $294.18 on Friday. The firm has a 50 day moving average of $297.72 and a 200-day moving average of $325.82. The stock has a market capitalization of $81.82 billion, a PE ratio of 27.75, a PEG ratio of 0.78 and a beta of 0.54. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83.

The Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same period in the previous year, the company earned $6.77 EPS. On average, equities research analysts predict that The Cigna Group will post 28.5 EPS for the current fiscal year.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.